HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endonuclease V Regulates Atherosclerosis Through C-C Motif Chemokine Ligand 2-Mediated Monocyte Infiltration.

Abstract
Background In cardiovascular diseases, atherosclerotic disorder are the most frequent and important with respect to morbidity and mortality. Inflammation mediated by immune cells is central in all parts of the atherosclerotic progress, and further understanding of the underlying mechanisms is needed. Growing evidence suggests that deamination of adenosine-to-inosine in RNA is crucial for a correct immune response; nevertheless, the role of adenosine-to-inosine RNA editing in atherogenesis has barely been studied. Several proteins have affinity for inosines in RNA, one being ENDOV (endonuclease V), which binds and cleaves RNA at inosines. Data on ENDOV in atherosclerosis are lacking. Methods and Results Quantitative polymerase chain reaction on ENDOV mRNA showed an increased level in human carotid atherosclerotic plaques compared with control veins. Inosine-ribonuclease activity as measured by an enzyme activity assay is detected in immune cells relevant for the atherosclerotic process. Abolishing EndoV in atherogenic apolipoprotein E-deficient (ApoE-/-) mice reduces the atherosclerotic plaque burden, both in size and lipid content. In addition, in a brain stroke model, mice without ENDOV suffer less damage than control mice. Finally, lack of EndoV reduces the recruitment of monocytes to atherosclerotic lesions in atherogenic ApoE-/- mice. Conclusions ENDOV is upregulated in human atherosclerotic lesions, and data from mice suggest that ENDOV promotes atherogenesis by enhancing the monocyte recruitment into the atherosclerotic lesion, potentially by increasing the effect of CCL2 activation on these cells.
AuthorsXiang Yi Kong, Camilla Huse, Kuan Yang, Jonas Øgaard, Natalia Berges, Erik Sebastian Vik, Meh Sameen Nawaz, Ana Quiles-Jiménez, Azhar Abbas, Ida Gregersen, Sverre Holm, Vigdis Bjerkli, Azita Rashidi, Cathrine Fladeby, Rajikala Suganthan, Ellen Lund Sagen, Mona Skjelland, Anna Lång, Stig Ove Bøe, Magnar Bjørås, Pål Aukrust, Ingrun Alseth, Bente Halvorsen, Tuva Børresdatter Dahl
JournalJournal of the American Heart Association (J Am Heart Assoc) Vol. 10 Issue 14 Pg. e020656 (07 20 2021) ISSN: 2047-9980 [Electronic] England
PMID34259011 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Cytokines
  • RNA
  • Deoxyribonuclease (Pyrimidine Dimer)
Topics
  • Aged
  • Animals
  • Aorta, Thoracic (metabolism, pathology)
  • Atherosclerosis (genetics, metabolism, pathology)
  • Chemokine CCL2 (biosynthesis, genetics)
  • Cytokines
  • Deoxyribonuclease (Pyrimidine Dimer) (biosynthesis, genetics)
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Gene Expression Regulation
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monocytes (metabolism, pathology)
  • RNA (genetics)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: